Jack Burnett has acquired 4.67 million common shares of RAMM PHARMA Corp, increasing his stake to 22.38% in the Company, reflecting his confidence in its growth potential in the Canadian pharmaceutical sector.
Information on the Target
RAMM PHARMA Corp (CSE: RAMM) is a publicly traded pharmaceutical company based in Canada. The Company focuses on developing and delivering innovative healthcare solutions, aiming to enhance the quality of life for patients through cutting-edge pharmaceutical products.
With its commitment to research and development, RAMM PHARMA is positioned to capitalize on emerging trends within the pharmaceutical sector, ensuring a robust pipeline of future offerings that meet evolving market demands.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Canada
The Canadian pharmaceutical industry is characterized by a strong regulatory framework and a growing emphasis on research and innovation. Canada has a we
Similar Deals
Nova Leap Health Corp. → two affiliated home care businesses and a home care business
2025
Jack Burnett
invested in
RAMM PHARMA Corp
in 2025
in a Other deal
Disclosed details
Transaction Size: $35M